These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28641570)

  • 1. 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity.
    Popovic DS; Tomic-Naglic D; Mitrovic M; Zivanovic Z; Vukovic B; Stokic E
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):226-237. PubMed ID: 28641570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity.
    Popovic DS; Mitrovic M; Tomic-Naglic D; Icin T; Bajkin I; Vukovic B; Benc D; Zivanovic Z; Kovacev-Zavisic B; Stokic E
    Curr Neurovasc Res; 2017; 14(3):200-206. PubMed ID: 28625128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].
    Tobisch B; Blatniczky L; Barkai L
    Orv Hetil; 2011 Jul; 152(27):1068-74. PubMed ID: 21676673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers.
    Arthur FK; Adu-Frimpong M; Osei-Yeboah J; Mensah FO; Owusu L
    Lipids Health Dis; 2012 Aug; 11():101. PubMed ID: 22883105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity.
    Popovic DS; Stokic E; Mitrovic M; Tomic-Naglic D; Pejin R; Icin T; Vukovic B; Zivanovic Z; Pejakovic S; Kovacev-Zavisic B
    Curr Vasc Pharmacol; 2017; 15(4):380-389. PubMed ID: 28155627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Turner Syndrome-Associated Hyperglycemia: Evaluating Hemoglobin A1c and Fasting Blood Glucose.
    Parra Villasmil MG; Ryckman KK; Norris AW; Pinnaro CT
    Horm Res Paediatr; 2024; 97(4):374-382. PubMed ID: 37788658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.
    Khera R; Pandey A; Chandar AK; Murad MH; Prokop LJ; Neeland IJ; Berry JD; Camilleri M; Singh S
    Gastroenterology; 2018 Apr; 154(5):1309-1319.e7. PubMed ID: 29305933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
    Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
    Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals.
    Temelkova-Kurktschiev T; Koehler C; Schaper F; Henkel E; Hahnefeld A; Fuecker K; Siegert G; Hanefeld M
    Diabetologia; 1998 Jun; 41(6):706-12. PubMed ID: 9662054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of sRAGE Are Associated with Body Measurements, but Not Glycemic Parameters in Patients with Prediabetes.
    Guclu M; Ali A; Eroglu DU; Büyükuysal SO; Cander S; Ocak N
    Metab Syndr Relat Disord; 2016 Feb; 14(1):33-9. PubMed ID: 26569122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.
    Amin RF; El Bendary AS; Ezzat SE; Mohamed WS
    Diabetes Metab Syndr; 2019; 13(3):2226-2229. PubMed ID: 31235161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome.
    Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Huţanaşu IC; Ungureanu D; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):692-9. PubMed ID: 23272512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile.
    Serbis A; Giapros V; Challa A; Chaliasos N; Siomou E
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):757-764. PubMed ID: 30229983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical and laboratory markers of cardiometabolic risk in overweight and obese children and adolescents.
    Palhares HM; da Silva AP; Resende DC; Pereira GA; Rodrigues V; Borges MF
    Clinics (Sao Paulo); 2017 Jan; 72(1):36-43. PubMed ID: 28226031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
    Bergman M; Chetrit A; Roth J; Dankner R
    Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study.
    Farcas AD; Vonica CL; Golea A
    Med Ultrason; 2017 Jun; 19(3):265-271. PubMed ID: 28845491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.